Bausch + Lomb acquires Trukera Medical

Bausch + Lomb has acquired Trukera Medical from AccelMed Partners, to help expand its surgical presence in the US and further strengthen its position in the dry eye market.

Trukera Medical, a US-based ophthalmic medical diagnostic company, commercialises ScoutPro, a point-of-care portable device for measuring osmolarity, with hyperosmolarity (not detectable by slit lamp examination) being the leading indicator of dry eye disease.

‘As a global leader in dry eye disease management, as well as cataract and refractive medical devices and implants, we’re uniquely positioned to optimise pre-surgical preparation to help ensure positive post-surgical outcomes,’ said Luc Bonnefoy, president of global surgical at Bausch + Lomb.